Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BICO Group AB Class B ( (SE:BICO) ) has provided an announcement.
BICO Group AB announced the release of its Q2 2025 interim report scheduled for August 19, 2025. The report will be followed by a telephone conference hosted by the company’s President & CEO Maria Forss and CFO Jacob Thordenberg, providing stakeholders an opportunity to engage and ask questions. This event underscores BICO’s commitment to transparency and stakeholder engagement, potentially impacting its market positioning and investor relations.
More about BICO Group AB Class B
BICO Group AB is a lab automation partner and provider of selected workflows to the pharmaceutical and biotech industries. With over 48,000 instruments installed in more than 65 countries, BICO’s products, software, and solutions are utilized in over 3,500 laboratories, including the top 20 pharmaceutical companies globally. The company operates through two business areas: Lab Automation and Life Science Solutions, aiming to enable and automate future life science labs. BICO is listed on the Mid-Cap, Nasdaq Stockholm under the ticker BICO.
Average Trading Volume: 127,030
Technical Sentiment Signal: Sell
Current Market Cap: SEK2.54B
For an in-depth examination of BICO stock, go to TipRanks’ Overview page.